| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $10.5M | -19.8% | -19.4% |
| SG&A Expense | $4.4M | -20.4% | -24.0% |
| Operating Income | -$15.0M | +20.0% | +20.8% |
| Income Tax | $0 | — | — |
| Net Income | -$14.2M | +19.9% | +15.5% |
| EPS (Basic) | -$0.52 | +20.0% | +16.1% |
| EPS (Diluted) | -$0.52 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $137.8M | -6.6% | -24.2% |
| Current Assets | $139.4M | -6.9% | -24.0% |
| Total Assets | $147.0M | -6.9% | -23.3% |
| Current Liabilities | $9.0M | +11.3% | -35.5% |
| Long-term Debt | $20.3M | +1.0% | +100.0% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$40.3M | — | — |
| Capital Expenditures | $24K | — | — |
| Investing Cash Flow | -$24K | — | — |
| Financing Cash Flow | $9.9M | — | — |
| Free Cash Flow | -$40.3M | — | — |
| +16.1% |
| $35.4M |
| +2.9% |
| +33.5% |
| Stockholders' Equity | $111.6M | -9.6% | -32.4% |